Dr. Sarah Goldberg: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?

Spreaker is getting a new look!

Preview our new listening experience personalized just for you.

Dr. Sarah Goldberg: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?

GRACEcast

00:00

04:01

Like Download

Dr. Sarah Goldberg, from Yale Cancer Center, offers her insights on how to approach a patient with gradual progression in a single site, especially in the brain, or more multifocal progression after a good initial response to a targeted agent.

10 years ago #acquired, #cancer, #cancergrace, #center, #chemotherapy, #disease, #goldberg, #grace, #gracecast, #progression, #resistance, #sarah, #targeted, #therapy, #yale

0 Comments

This episode has no messages yet. Be the first to write a message!

Spreaker is getting a new look!

Dr. Sarah Goldberg: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?

Dr. Sarah Goldberg: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?

0 Comments

For Creators

For Listeners & Advertisers

Choose Language

Follow us